A Phase 3 Clinical Study of NI-071 in Patients With Rheumatoid Arthritis −A Double-blind, Active Drug-controlled Study and Long-term Study−
Phase of Trial: Phase III
Latest Information Update: 09 Nov 2016
Price : $35 *
At a glance
- Drugs Infliximab (Primary)
- Indications Rheumatoid arthritis
- Focus Registrational; Therapeutic Use
- Sponsors Nichiiko Pharmaceutical
- 06 Apr 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Sep 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 26 Aug 2013 New trial record